Synthesis of (di)nucleoside polyphosphates by the ubiquitin activating enzyme E1  by Günther Sillero, Maria A. et al.
FEBS 30090 FEBS Letters 579 (2005) 6223–6229Synthesis of (di)nucleoside polyphosphates by the ubiquitin
activating enzyme E1
Maria A. Gu¨nther Sillero, Anabel de Diego, Eduardo Silles, Antonio Sillero*
Departamento de Bioquı´mica, Instituto de Investigaciones Biome´dicas Alberto Sols UAM/CSIC, Facultad de Medicina, 28029 Madrid, Spain
Received 29 August 2005; revised 22 September 2005; accepted 4 October 2005
Available online 14 October 2005
Edited by Lev KisselevAbstract Previous work from this laboratory had shown that
ligases may catalyze the synthesis of (di)nucleoside polyphos-
phates. Here, we show that one of the enzymes of the proteasome
system (E1 or the ubiquitin (Ub) activating enzyme, EC 6.3.2.19)
catalyzes very eﬀectively (kcat = 0.29 ± 0.05 s
1) the transfer of
AMP from the E–AMP–ubiquitin complex to tripolyphosphate
or tetrapolyphosphate with formation of adenosine tetra- or pen-
taphosphate (p4A or p5A), respectively. Whereas the concomi-
tant formation of AMP is stimulated by the presence of
dithiothreitol in a concentration dependent manner, the synthesis
of p4A is only slightly inhibited by this compound. Previous
treatment of the enzyme (E1) with iodoacetamide inhibited only
partially the synthesis of p4A. p4A can substitute for ATP as sub-
strate of the reaction to generate the ubiquityl adenylate com-
plex. A small amount of diadenosine pentaphosphate (Ap5A)
was also synthesized in the presence of p4A.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Tripolyphosphate1. Introduction
Based on previous results obtained by others on aminoacyl t-
RNAsynthetases [1], we suggested that all the enzymes classiﬁed
as AMP-forming ligases could be considered as potentially able
to catalyze the synthesis of dinucleoside polyphosphates [2]. This
proved to be the case for a variety of enzymes, including lucifer-
ase, acetyl-CoA synthetase, acyl-CoA synthetase, T4 RNA li-
gase, T4 DNA ligase, and others (for a review see [3]).
Ligases catalyze the synthesis of diadenosine tetraphosphate
(Ap4A) and other (di)nucleoside polyphosphates through the
general reactions shown in Eqs. (a) and (b) below:Abbreviations: Ap4A, adenosine (5
0) tetraphospho (50) adenosine or
diadenosine tetraphosphate; Ap4N, adenosine (5
0) tetraphospho (50)
nucleoside; BSA, bovine serum albumin; DTT, dithiothreitol; Ub,
ubiquitin; AMP–Ub, ubiquityl adenylate; IAA, iodoacetamide; NTP,
nucleoside triphosphate; PPase, pyrophosphatase; P3, tripolyphos-
phate; P4, tetrapolyphosphate; P5, pentapolyphosphate; P15, linear-
chain polyphosphates with an average chain length of 15 ± 3; p4A,
adenosine 50-tetraphosphate; p5A, adenosine 5 0-pentaphosphate; p4G,
guanosine 50-tetraphosphate
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doi:10.1016/j.febslet.2005.10.003(a) E + X + ATPM E–X–AMP + PPi
(b) E–X–AMP + ATPﬁ Ap4A + X + E
As reaction (a) is reversible, the synthesis of Ap4A is greatly
favored in the presence of pyrophosphatase (PPase). In our
experience, reaction (b) is rather unspeciﬁc and the AMP res-
idue of the E–X–AMP complex (or E–AMP in some cases
[3]) may react with the terminal phosphate of almost any mol-
ecule containing an intact terminal P–P–P, such as tripoly-
phosphate (P3), tetrapolyphosphate (P4), pentapolyphosphate
(P5) ATP, GTP, adenosine 5
0-tetraphosphate (p4A), guanosine
5 0-tetraphosphate (p4G), etc. In the case of luciferase, the moi-
ety of AMP from E–luciferin–AMP can even be transferred to
polyphosphates as long as linear-chain polyphosphates with an
average chain length of 15 ± 3 (P15) giving rise to a family of
compounds as bizarre as p16A, p20A, Ap15A, Ap16A, etc. [4].
Following this reasoning, we have paid attention to the
ubiquitin (Ub) system of degrading proteins, a complex meta-
bolic pathway thoroughly explored by the groups of Ciecha-
nover, Hershko, Rose and others [5–7]. The knowledge
developed by these authors on this system is the cornerstone
of the work shown below.
Two main processes can be considered in the proteasome
system (i) ubiquitination of proteins and (ii) the proteolytic
cleave of the tagged proteins by the 26 S proteasome complex
with liberation of Ub (Fig. 1). In the ﬁrst process, Ub is acti-
vated by the following enzymes: E1 (Ub activating enzyme),
E2s (Ub carrier proteins) and E3s (Ub–protein ligases) [8]. Fi-
nally, the ubiquitinated protein is degraded in the proteasome
with liberation of peptides and regeneration of Ub (Fig. 1).
Here we shall center our attention on E1. This enzyme is a
homodimer composed of two subunits of 105 kDa [9]. The
three reactions catalyzed by this enzyme, represented diagram-
matically in Fig. 1 [10,11], can be summarized in the following
global equation:
Eþ 2Ubþ 2ATP$ ub–s–Eamp–ubþAMPþ 2PPi
In order to simplify the presentation of this work, two
‘‘functional regions’’ (regions in subsequent lines), A–U
(acronym of AMP–ubiquitin) and U (from ubiquitin) are
considered in E1 (Fig. 1). The synthesis of ubiquityl adenyl-
ate (AMP–Ub) and the ﬁrm, but non-covalent, attachment
of this complex to region A–U of the enzyme take place
with liberation of PPi (Fig. 1, step 1). In step 2, the Ub moi-
ety of the EAMP–Ub complex is transferred from the region
A–U to a sulfhydryl residue in the area U of E1, with lib-
eration of AMP. In step 3, similar to step 1, an AMP–Ub
complex is attached to region A–U of the enzyme. In the
presence of E2, the Ub moiety on area U is transferred to
E2 and the region U of E1 (unoccupied now by Ub) isblished by Elsevier B.V. All rights reserved.
Fig. 1. Ubiquitin system and potential degradation of proteins in the proteasome. Three interconnected pathways can be considered in this process:
E1 or ubiquitin activating enzyme, E2 or ubiquitin carrier proteins and E3 or ubiquitin protein ligases. Whereas only one type of E1 is known, many
species of E2 and multiple families of E3 have been described. The (poly)ubiquitinated protein is degraded in the proteasome. Here, E1 is represented
with the form of an angle to facilitate the location of the two functional regions: for the formation of EAMP–Ub (right arm or A–U region) and for the
coupling of ubiquitin to a –SH residue of the enzyme (left arm or U region). For details of steps 1–5, see text.
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and (potentially) digested by the proteasome is tagged
through additional steps 4, 5 and 6 (Fig. 1).
The Enzyme Commission assigns the number EC 6.3.2.19 to
the reaction catalyzed by E1 or to the total process of ubiqui-
tination of the target protein catalyzed by E1, E2 and E3
ATPþ ubiquitinþ ubiquitin–protein ligase
¼ AMPþ protein N–ubiquitinþ PPiIn our view, E1 is a special type of ligase as it catalyzes: (i) the
ﬁrst step of a ligase, i.e.: formation of the AMP–Ub complex
and (ii) the binding of the activated Ub to a –SH group in a
Cys residue of E1, in a thiolester linkage: in this case, the prop-
er enzyme E1 serves as the other substrate of the reaction
aﬀording the –SH residue to which the carboxyl end of Ub is
joined [11,12] (Fig. 1).
Based on previous results with other ligases we consid-
ered that the enzyme E1 could also be a candidate to cat-
alyze the synthesis of (di)nucleoside polyphosphates.
Experiments showing that E1 catalyzes the synthesis of
p4A and adenosine 5
0-pentaphosphate (p5A), and to a
small extent the synthesis of a dinucleotide such as
Ap5A, are described below.2. Materials and methods
2.1. Materials
Ub activating enzyme (E1) (110 kDa) (Ref. U1758; lot numbers
064K2742; 025K2733); Ub (U6253); sodium tripolyphosphate and
hexaammonium tetrapolyphosphate were from Sigma. Yeast inorganic
PPase (EC 3.6.1.1) was from Roche Molecular Biochemicals. [a-32P]
ATP (3000 Ci/mmol) was from Amersham. TLC silica-gel ﬂuorescent
plates were from Merck. Radioactively labeled nucleotides were quan-
tiﬁed with the help of an InstantImager (Packard Instrument Co.).
HPLC was carried out in a Hewlett Packard chromatograph (model
1090) with a diode array detector. The Hypersil ODS column
(4.6 · 100 mm) was from Hewlett Packard.
2.2. Synthesis of nucleoside polyphosphates by Ub activating enzyme
(E1)
Unless otherwise indicated the reaction mixtures contained 50 mM
Tris/HCl (pH 7.5), 9 mM MgCl2, 0.05 lg PPase, 6 lM Ub, 0.05% bo-
vine serum albumin (BSA), ATP, dithiothreitol (DTT), polyphos-
phates and E1, as indicated. When required the enzyme (E1) was
diluted in 0.1 M Tris/HCl, pH 7.5/0.5% BSA. A molecular mass of
110 kDa was considered to calculate the concentration of E1. After
incubation at 37 C the reaction mixtures were analyzed by one of
the following methods.
TLC. The reaction mixtures (0.02 ml) contained 0.02 mM [a-32P]
ATP (0.4 lCi). Aliquots of 1.5 ll of the reaction were spotted on silica
gel plates and developed for 2 h in dioxane:ammonium hydrox-
ide:water (6:1:6 by volume). Radioactivity was measured by autoradi-
ography and/or with an InstantImager.
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58 lM Ub, 20 mM DTT, and 0.8 mM P3, P4 or p4A, as indicated,
and 4.5 pmol of E1. After incubation at 37 C for 16 h the mixtures
were transferred into 0.180 ml of water and kept at 95 C for
1.5 min. Aliquots of 0.05 ml were analyzed by HPLC as described in
[13].3. Results and discussion
3.1. Synthesis of p4A by the Ub activating enzyme E1
Since an Ub-dependent ATP:PPi exchange had been shown
to be catalyzed by E1 [8,10–12], we wondered if P3 in the pres-
ence of PPase could also be an acceptor of the AMP moiety of
the EAMP–Ub complex. As shown in Fig. 2, when E1 was incu-
bated in the presence of 0.02 mM [a-32P] ATP, 0.8 mM P3, and
in the absence or presence of PPase, the formation of a com-
pound migrating slower than ATP, in the same position as a
marker of p4A, and of another one corresponding to AMP
were detected (Fig. 2A). The formation of both AMP and
p4A was enzyme dependent. The presence of PPase in the reac-
tion mixture doubled the rate of synthesis of p4A (Fig. 2B) and
decreased about 25% the rate of synthesis of AMP (Fig. 2C).
The apparent Km values determined for ATP for the synthe-
sis of p4A (in the presence of 0.8 mM P3 and 6 lM Ub), for P3
(in the presence of 20 lM ATP and 6 lM Ub) and Ub (in the
presence of 20 lM ATP and 0.8 mM P3) were 4.9 ± 0.8 lM,
2.8 ± 0.6 mM and 2.0 ± 0.5 lM, respectively (results notFig. 2. Synthesis of p4A catalyzed by the ubiquitin activating enzyme E1
6 lM Ub; 0.8 mM P3; 20 mM DTT; E1 (1.5 pmol or 0.17 lg) and PPase (0
(A) At diﬀerent times of incubation, aliquots were spotted on TLC plat
subjected to autoradiography. [a-32P] p4A and [a-
32P] AMP (pmol) forme
respectively.shown). The rate of synthesis (kcat) of p4A in the presence of
0.8 mM P3 was 0.29 ± 0.05 s
1.
3.2. Synthesis of p4A, p5A and minor amounts of Ap5A
To get a better knowledge of the reaction catalyzed by E1,
the reaction mixtures were also analyzed by HPLC. From
the chromatograms depicted in Fig 3, the following conclu-
sions could be drawn: in the absence of E1, only peaks corre-
sponding to ATP, contaminant ADP and DTT were observed
(Fig. 3A); in the presence of E1 and in the absence of P3, a
small peak corresponding to AMP was observed (Fig. 3B);
in the presence of P3, a signiﬁcant amount of ATP was con-
verted into p4A (Fig. 3C); in the absence of PPase the synthesis
of p4A was signiﬁcantly reduced (Fig. 3D); the formation of
both p4A and AMP was Ub dependent (Fig. 3E); P4 seemed
to be almost as good substrate as P3 as evidenced by the
amount of p5A formed in the presence of P4; the concomitant
synthesis of p4A observed in this chromatogram (Fig. 3F) is
due to the contaminant P3 present in the commercial sample
of P4 [4,14]. In the presence of 0.8 mM p4A a very small
amount of Ap5A was also synthesized (Fig. 3G).
In experiments aiming to check whether the moiety of AMP
from the EAMP–Ub complex could be transfer to a nucleoside
triphosphate (NTP) with formation of adenosine (5 0) tetra-
phospho (5 0) nucleoside (Ap4N), reaction mixtures, containing
ATP and PPase, were supplemented with either 0.8 mM GTP
or UTP but the syntheses of the potential products, Ap4G or
Ap4U, were not observed (results not shown). In the presence. The reaction mixtures contained: 0.02 mM [a-32P] ATP (0.4 lCi);
.05 lg), when indicated. Other components as indicated in Section 2.
es, developed with dioxane:ammonium hydroxide:water (6:1:6) and
d in the absence or presence of PPase are represented in B and C,
Fig. 4. Inﬂuence of DTT on the synthesis of p4A and AMP. Reaction
mixtures (in duplicate) contained: 0.02 mM [a-32P] ATP (0.4 lCi);
6 lM Ub; 0.8 mM P3; 0.05 lg PPase; 0; 1; 5 and 20 mM DTT as
indicated, and 1 pmol of E1. After 10 min of incubation, aliquots were
spotted on TLC plates, developed with dioxane:ammonium hydrox-
ide:water (6:1:6) and subjected to autoradiography.
Fig. 5. Synthesis of p4A. Inﬂuence of the pre-treatment of E1 with
IAA. E1 at a ﬁnal concentration of 0.75 nmol/ml was incubated in
50 mM Tris–HCl, pH 7.5, and 1 mg/ml BSA for 30 min at 37 C in
the absence or presence of 0.5 mM IAA. (A) Aliquots containing
1.5 pmol of E1 were used to determine its capacity to synthesize p4A
as in Fig. 4, but omitting DTT in the assay. (B) pmoles of p4A
synthesized.
Fig. 3. Synthesis of p4A, p5A and Ap5A catalyzed by the ubiquitin
activating enzyme E1. The reaction mixtures contained 0.8 mM P3 (C,
D, E); 0.8 mM P4 (F); or 0.8 mM p4A (G). Other components as
indicated in Section 2. Controls were carried out in the absence of E1
(A), Ub (E) or PPase (D). Aliquots were analyzed by HPLC as
described [13]. The arrow in part B of the ﬁgure indicates the elution
time of a marker of Ap4A.
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ATP to form Ap4A, was never observed.
3.3. Inﬂuence of DTT and iodoacetamide on the rate of synthesis
of p4A and AMP
These experiments were performed based on previous ﬁnd-
ings [8,15] showing that the transfer of Ub from the EAMP–
Ub complex in region A–U to the region U of E1 was inhibited
by iodoacetamide (IAA) and by DTT in diﬀerent ways: IAA
reacts with the cysteine residue of region U, and DTT reacts
with the activated Ub in the EAMP–Ub complex, hindering its
reaction with the –SH residue in the region U.
As shown in Fig. 4, in the absence of DTT the amount of
AMP synthesized is very low and the AMP moiety of the com-
plex EAMP–Ub reacts mainly with P3 to form p4A (Fig. 4, lanes
2–3). As the amount of DTT increases, the rate of formation of
AMP also increases in a concentration dependent manner due
to the cleavage of the enzyme-bound Ub adenylate by DTT
[15] (Fig. 4). In the presence of 20 mM DTT, while the hydro-
lysis of ATP to AMP increased from 0.2 to 4.1 pmol/min/pmol
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value of 14.5 pmol/min/pmol of E1 (Fig. 4, lanes 8–9).
The eﬀect of IAA had been previously tested [15] and found
that there was a selective derivatization of the thiol site re-
quired for Ub thiolester formation and that the derivatized en-
zyme still retained 86% of the ATP:PPi exchange activity. In
our working conditions when E1 was pre-treated with
0.5 mM IAA for 30 min at 37 C as described in [15], but omit-
ting DTT, the synthesis of p4A decreased by 32 ± 5% (n = 4)
(Fig. 5A and B), which points to step 1 (Fig. 1) as the main
source of p4A, although the possibility that the complex Ub–
S–EAMP–Ub, as well as a IAA derivatized complex, could be
able to react with P3 cannot be ruled out.
3.4. Linearity with the amount of enzyme: p4A as substrate of
the reaction
Diﬀerent amounts of enzyme (0.5; 1; 2 and 4 pmol of E1)
were added to reaction mixtures containing 0.8 mM P3 and ali-
quots spotted on TLC plates after 5, 10, 20, 40 120 min and
22 h of incubation (Fig. 6A). The linearity with the amount
of E1 in the ﬁrst 5 min of the reaction is shown in Fig. 6B.Fig. 6. Linearity with the amount of enzyme. The reaction mixtures contained
0.05 lg PPase, 2 mM DTT, 0.05% BSA and E1 as indicated. (A) At diﬀeren
with dioxane:ammonium hydroxide:water (6:1:6) and subjected to autorad
Synthesis and degradation of p4A, along time of incubation, in the presenceIn the presence of 4 pmol of E1 and after 20 min incubation,
the ATP had been completely transformed into p4A. Further
incubation of this mixture converted gradually the p4A into
AMP (Fig. 6C). The same conversion occurred at the other en-
zyme concentrations although at lower rates. From these re-
sults, it seems as p4A could substitute ATP in establishing
the following equilibrium:
EþUbþ p4A$ Eamp–ubþ P3
and that the complex EAMP–Ub, due to the presence of DTT in
the reaction mixture, is slowly degraded liberating AMP [15].
Further evidence that p4A is substrate of the reaction was
obtained incubating the enzyme E1 (for 6 h) in the presence
of 0.25 mM p4A and 2 mM PPi as in Fig. 3, but in the absence
of PPase and DTT: in this conditions a 80% of the p4A was
transformed into ATP (results not shown).
3.5. Concluding remarks
The work presented above is based on previous results ob-
tained by others on the Ub system [5–7] and in our previous
work [3] on the catalytic properties of the enzymes ligases.: 0.04 mM [a-32P] ATP (0.4 lCi); 12 lMUb; 0.8 mM P3; 9 mMMgCl2;
t times of incubation, aliquots were spotted on TLC plates, developed
iography. (B) pmoles of p4A synthesized after 5 min incubation. (C)
of 4 pmol E1.
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P4) in the presence of PPase (reaction (d)), replaces PPi in the
reverse of reaction (c):
(c) E + Ub + ATPM EAMP–Ub + PPi
(d) EAMP–Ub + P3M E + p4A + Ub
The possibility of reaction (d) to take place was implicit (but
it was not tested) in [11]. Haas et al. stated that ‘‘inorganic
phosphate, arsenate, methyl phosphate and triphosphate, but
not NTPs, can serve as alternate substrates in place of PPi in
the reverse of Ub adenylate formation’’. However, they did
not explore whether E1 did synthesize the expected derivatives.
The EAMP–Ub complex is the center of a small metabolic
crossroads that may follow diﬀerent routes (Fig. 7) depending
on the conditions of the assay mixture. In the presence of ATP
and Ub, and in the absence of PPase, the reaction reaches a
stationary phase in which 2 mol of Ub and 2 mol of ATP are
used for the formation of the complexes EAMP–Ub and Ub–
S–EAMP–Ub with liberation of 1 mol of AMP (see steps 1–3
in Fig. 1). In the presence of P3 and PPase the AMP moiety
from the EAMP–Ub complex is transferred to P3 with formation
of p4A (Fig. 7). Pre-incubation of the enzyme with IAA, that
prevents formation of the second complex, inhibited the syn-
thesis of p4A by only 32% in comparison to a non-treated en-
zyme. Based on this result, the synthesis of p4A seems to
proceed mainly through the EAMP–Ub complex but some syn-
thesis from the Ub–S–EAMP–Ub and IAA–S–EAMP–Ub complex
could also occur (Fig. 7). In the presence of DTT the synthesis
of p4A is slightly inhibited, due to the catalytic cleavage of the
enzyme-bound Ub-adenylate by DTT, with synthesis of DTT–
Ub and subsequent liberation of AMP from the EAMP–Ub and
Ub–S–EAMP–Ub complexes. Most probably, once AMP is liber-
ated from the complex is not apt for the synthesis of p4A.
Inorganic polyphosphates are probably present in every cell
[17–19] and are particularly abundant in yeast extracts whereFig. 7. Overview of possible reactions catalyzed by the ubiquitin
activating enzyme E1, in the presence of PPase and with participation
of ATP, Ub, P3, p4A, DTT and IAA. Synthesis of p4A can be obtained
by transfer of AMP from the E1 complexes, indicated in the ﬁgure, to
P3. In the presence of DTT the rate AMP formation is accelerated in a
concentration dependent manner and the synthesis of p4A results
slightly inhibited. IAA reacting with one critical SH-group in E1,
inhibits the formation of the Ub–S–EAMP–Ub complex, but not the
ATP:PPi exchange [15]. The synthesis of p4A with the IAA treated E1
decreased by about 32%. For more details see text.P3 and P4 have been described at mM concentrations [17].
As previously pointed out [16], the potential eﬀects carried
out by polyphosphates (here P3 and P4) can be considered un-
der two diﬀerent aspects: either due their presence at high con-
centration and frequently condensed in organelles or due to
their occurrence at low concentration in diﬀerent cellular com-
partments. Although their role in the last case is not clear,
there is a common concern about the possibility of polyphos-
phates playing more general and universal functions in biology
[14,17–20]. Being this so, these speciﬁc eﬀects would entail the
action of polyphosphates at (sub) lM concentration in animal
cells [19]. In the case of E1, it is diﬃcult for us to envisage the
physiological role of P3, considering its high apparent Km value
prevailing in the reactions here described and the expected low
concentrations of P3 present in the cytosol of animal cells.
Nevertheless, E1 could be contemplated as one of the AMP-
forming ligases able to catalyze the synthesis of p4A from
ATP and P3 [3]. The occurrence of p4A has been described
in chromaﬃn granules of the adrenal medulla [21], in skeletal
and cardiac muscle [22,23], and in yeast [24]. p4A has been in-
volved in yeast sporulation [24] and as a modulator of cardiac
vascular tone [23]. p4A could modulate also indirectly the lev-
els of Ap4A and Ap4N (nucleotides whose physiological role
seems to be elusive [25,26]), by inhibiting (Ki, nM) the activity
of the (asymmetrical) dinucleoside tetraphosphatase (EC
3.6.1.17) [27]. In another context, the eﬀect of P3 could also
be contemplated from a pharmacological point of view. In this
sense, experiments are being carried out in this laboratory to
explore the possible eﬀect of P3 on the degradation of proteins,
using the reticulocyte system.
Finally, it could be recall that, in our hands, no observable
synthesis of Ap4A (from ATP) or Ap4N (from ATP + UTP
or GTP) was obtained with E1. As shown previously by others
NTPs cannot serve as alternative substrates in place of PPi in
the reverse of Ub adenylate formation [11]. This property ex-
cludes E1 as an enzyme participating in the rise of Ap4N after
metabolic stress [28]. It seems as if this active site of E1 could
accommodate P3 or P4, but not the bulky residue of a nucleo-
side attached to one of their ends. The enzyme speciﬁcity of E1
(compared with that of other ligases) could be better under-
stood with a deeper knowledge of the crystallographic struc-
tures and the topography of the active areas of these enzymes.
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